慢性胰腺炎患者胰腺内镜治疗的应用:美国多中心队列研究结果
该研究为PROCEED多中心队列的横断面分析,681例慢性胰腺炎患者中238例(34.9%)接受胰腺内镜治疗(PET)。与接受PET相关的因素包括女性、低教育程度、年收入≤5万美元及既往急性胰腺炎。238例中103例(43.3%)在中位2年时接受重复PET。
要点
- 681例慢性胰腺炎患者中238例(34.9%)接受PET,以ERCP为主。
- 女性、低教育程度、年收入≤5万美元及既往急性胰腺炎与接受PET相关。
- 238例中103例(43.3%)在中位2年时接受重复PET。
核心结论
- 接受PET的慢性胰腺炎患者中近半数在2至3年内接受1次或以上重复疗程。
- 除既往急性胰腺炎史外,人口学和社会经济因素与接受PET相关。
研究设计与样本
- PROCEED美国多中心慢性胰腺炎队列研究的横断面分析。
- 共纳入681例受试者,其中238例(34.9%)接受PET。
- PET方式主要为ERCP;一个疗程定义为针对特定指征进行的操作次数。
- 重复疗程定义为末次疗程完成后超过1年再行PET。
- 采用多变量logistic回归识别接受PET的预测因素,采用比例率模型评估重复PET的危险因素。
主要发现
- 681例中238例(34.9%)接受PET。
- 接受PET的相关因素包括女性(OR 1.26;95%CI 1.03-1.53)、低教育程度(OR 1.30;95%CI 1.04-1.62)、年收入≤5万美元(OR 1.35;95%CI 1.07-1.71)及既往急性胰腺炎(OR 1.74;95%CI 1.31-2.32)。
- 238例中103例(43.3%)在中位2年时接受重复PET。
- 238例中23.1%接受2个疗程,9.7%接受3个疗程,10.4%接受≥4个疗程。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Although pancreatic endotherapy (PET) is commonly used for treating adverse events of chronic pancreatitis, data on the frequency and factors associated with the use of PET are limited. Our aim was to define the use of and factors predictive for receiving PET in a well-characterized chronic pancreatitis cohort. METHODS: This is a cross-sectional analysis of data from PROCEED, a multicenter U.S. cohort study of chronic pancreatitis. PET modalities primarily consisted of ERCP. A treatment course was defined as the number of sessions performed for a specific indication. A repeat course was defined as PET >1 year after completion of the last course. Multivariable logistic regression identified predictive factors for receiving PET, and proportional rates model assessed risk factors for repeat PET. RESULTS: Of 681 subjects, 238 (34.9%) received PET. Factors associated with receiving PET included female sex (odds ratio [OR], 1.26; 95% confidence interval [CI], 1.03-1.53), lower education (OR, 1.30; 95% CI, 1.04-1.62), income ≤$50,000 per year (OR, 1.35; 95% CI, 1.07-1.71), and prior acute pancreatitis (OR, 1.74; 95% CI, 1.31-2.32). Of 238 subjects, 103 (43.3%) underwent repeat PET at a median duration of 2 years, with 23.1% receiving 2 courses, 9.7% receiving 3 courses, and 10.4% receiving ≥4 courses. CONCLUSIONS: Nearly half of patients with chronic pancreatitis who undergo PET received 1 or more repeat courses within 2 to 3 years. In addition to a prior history of acute pancreatitis, demographic and socioeconomic factors were associated with receiving PET.
引用
- Han S, Conwell DL, Easler JJ, et al. Use of pancreatic endotherapy in patients with chronic pancreatitis: results from a multicenter cohort study in the United States. Gastrointest Endosc. 2024. PMID: 38583544. doi:10.1016/j.gie.2024.04.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。